Roche reports positive Phase 3 data with its investigational breast cancer drug giredestrant.
FDA posts a draft guidance entitled Malaria: Developing Drugs for Treatment that outlines key considerations for companies developing drugs targeting ...
Lexicon Pharmaceuticals says FDA is requiring additional time to review its new clinical data submitted earlier this month in an effort to advance its...
FDA accepts for priority review a Chiesi NDA for idebenone and its use in treating Leber hereditary optic neuropathy.
FDA escalates medical device oversight this year, issuing more Warning Letters and relying on artificial intelligence to zero-in on compliance gaps, a...
Rep. Frank Pallone Jr. (D-NJ) sharply criticizes Health and Human Services Secretary Robert F. Kennedy Jr., accusing him of undermining vaccine access...
FDA approves Medtronics Altaviva implantable tibial neuromodulation device for treating urge urinary incontinence.
FDA schedules a 10/9 Vaccines and Related Biological Products Advisory Committee meeting to make recommendations on the strain selection for influenza...
